[Migraine: use of preventive agents].
Takei
K
K
Shimazu
K
K
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004878:Ergotamine / Q000627:therapeutic use; D006801:Humans; D008881:Migraine Disorders / Q000517:prevention & control*; D012702:Serotonin Antagonists / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D000927:Anticonvulsants; D000928:Antidepressive Agents; D002121:Calcium Channel Blockers; D012702:Serotonin Antagonists; D004878:Ergotamine